Showing results (1-10 of 49) with videos related to

Sort By:
Pageof 5
PPAR Research|September 10, 2008
PPARgamma: The Portrait of a Target Ally to Cancer Chemopreventive AgentsIoannis Sainis, Katerina Vareli, Vasilios Karavasilis, et al.
Scandinavian Journal of Infectious Diseases|December 13, 2005
Pseudomonas fluorescens infections in clinical practiceGeorgios Pappas, Vasilios Karavasilis, Leonidas Christou, et al.
Case Reports in Dermatology|February 28, 2014
Acquired ichthyosis triggered by an osseous hemangiopericytoma: a case report and review of the literatureAikaterini Patsatsi, Aikaterini Kyriakou, Vasilios Karavasilis, et al.
Cancer|February 19, 2008
Significant clinical benefit of first-line palliative chemotherapy in advanced soft-tissue sarcoma: retrospective analysis and identification of prognostic factors in 488 patientsVasilios Karavasilis, Beatrice M Seddon, Susan Ashley, et al.
Cancer Management and Research|February 15, 2018
Advances in the treatment of soft tissue sarcoma: focus on eribulinPanagiotis Koliou, Vasilios Karavasilis, Maria Theochari, et al.
Future Oncology (London, England)|January 31, 2017
Novel therapeutic approaches in chondrosarcomaGenovefa Polychronidou, Vasilios Karavasilis, Seth M Pollack, et al.
Journal of Neurology|January 8, 2013
A phase I study of temozolomide and lapatinib combination in patients with recurrent high-grade gliomasVasilios Karavasilis, Vassiliki Kotoula, George Pentheroudakis, et al.
Oncotarget|December 31, 2016
Assessing the clinical value of microRNAs in formalin-fixed paraffin-embedded liposarcoma tissues: Overexpressed miR-155 is an indicator of poor prognosisNikolaos Kapodistrias, Konstantinos Mavridis, Anna Batistatou, et al.
The Journal of Antimicrobial Chemotherapy|January 24, 2018
Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitalsFranziska Layer, Sophia Vourli, Vasilios Karavasilis, et al.
Journal of Experimental & Clinical Cancer Research : CR|September 21, 2012
Molecular predictors of response to tyrosine kinase inhibitors in patients with Non-Small-Cell Lung CancerSamuel Murray, Vasilios Karavasilis, Mattheos Bobos, et al.
Pageof 5